التفاصيل البيبلوغرافية
| العنوان: |
The spleen as an organ at risk in paediatric radiotherapy: A SIOP-Europe Radiation Oncology Working Group report. |
| المؤلفون: |
Arunagiri, Niruthiga1 (AUTHOR) niruthiga.arunagiri@nhs.net, Kelly, Sarah M.1,2,3 (AUTHOR) sarah.kelly@eortc.org, Dunlea, Cathy1 (AUTHOR) cathy.dunlea@nhs.net, Dixon, Olivia1 (AUTHOR) olivia.dixon@nhs.net, Cantwell, Jessica1 (AUTHOR) jessica.cantwell@nhs.net, Bhudia, Pravesh1 (AUTHOR) pravesh.bhudia@nhs.net, Boterberg, Tom4 (AUTHOR) Tom.Boterberg@UGent.be, Janssens, Geert O.5,6 (AUTHOR) G.O.R.Janssens@umcutrecht.nl, Gains, Jennifer E.1 (AUTHOR) jenny.gains@nhs.net, Chang, Yen-Ch'ing1 (AUTHOR) yenchingchang@nhs.net, Gaze, Mark N.1 (AUTHOR) mgaze@nhs.net |
| المصدر: |
European Journal of Cancer. Jan2021, Vol. 143, p1-10. 10p. |
| مصطلحات موضوعية: |
*MEDLINE, *ONCOLOGY, *PEDIATRICS, *PROFESSIONS, *RADIOTHERAPY, *RISK assessment, *SPLEEN, *SPLEEN diseases, *SYSTEMATIC reviews, *DISEASE risk factors |
| مصطلحات جغرافية: |
EUROPE |
| مستخلص: |
Radiation may cause long-term splenic dysfunction, risking potentially fatal late sepsis. We aimed to review this complication's magnitude in paediatric radiotherapy and gauge the level of awareness of the spleen as an organ at risk. Clinical trial protocols and radiotherapy guidelines, patient/parent information sheets, and professional guidance documents were reviewed to assess the perceived risk of radiotherapy-related splenic dysfunction. Paediatric oncologists and paediatric radiation oncologists across Europe were surveyed to estimate the level of understanding of this risk and to ascertain current practice. Spleen doses received in practice were examined. A systematic review of relevant publications was undertaken. The risk is not mentioned in most clinical trials, patient information leaflets, or professional guidance documents. When mentioned, a threshold dose of 40 Gy is cited. The survey showed only limited awareness. More than half of patients assessed received spleen doses in excess of 10 Gy. The systematic review identified one paper reporting a relative mortality risk of 5.5 with spleen doses in the 10–20 Gy range. The risk of mortality from overwhelming infection is poorly recognised. We therefore recommend routine delineation of the spleen. Protocols and guidelines should give a spleen dose objective as low as reasonably achievable, ideally mean <10 Gy without compromise to target volumes. Revised evidence-based guidelines and continuing professional development activities should inform oncologists. Patient/parent information should mention the risk and the dose received be communicated to colleagues. Antibiotic prophylaxis and/or (re)vaccination should be considered if the mean spleen dose is ≥10 Gy. • Incidental irradiation may impair splenic function in children. • This may be associated with a late risk of death due to overwhelming sepsis. • We demonstrate that this risk is not always recognised. • We make recommendations to increase awareness of the risk. • We recommend ways to mitigate this risk. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
